Mylana s (MYL) a oeSector Performa Rating Reaffirmed at Royal Bank of Canada


's stock had its "sector perform" rating reiterated by Royal Bank of Canada in a research note issued to investors on Monday, April 17th. They presently have a $46.00 price objective on the stock, down from their previous price objective of $48.00.



from Biotech News